GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Quest Diagnostics rises 2.98% in Thursday's session

Published by Global Banking & Finance Review

Posted on October 29, 2026

1 min read
Add as preferred source on Google
DGX 252.95 +2.98% last traded price, 29 Oct 2026
Previous close
245.62
Market cap
$27.9bn

The figures in this article were checked against this snapshot before publication.

Quest Diagnostics shares last traded at $252.95, 2.98% above their previous close of $245.62, on 29 October 2026. The company has a market value of $27.92bn in the health care sector in the United States.

Last traded price252.95 USD
Previous close245.62 USD
Change from the previous close+2.98%
Market value$27.92bn

Prices of Quest Diagnostics (DGX), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 29 October 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 28 October 2026. Market value is converted to US dollars at the ECB reference rate. We report a stock the day it ends a session 2% or more away from its previous close, where at least 100,000 shares traded in the previous session. How we compile these reports.

Quest Diagnostics — daily DGX Delayed

Related Articles

More from Markets

Explore more articles in the Markets category